• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺式阿曲库铵(51W89)在氧化亚氮-氧气-阿片类麻醉期间用于成年外科手术患者的药效学剂量反应及安全性研究。

Pharmacodynamic dose-response and safety study of cisatracurium (51W89) in adult surgical patients during N2O-O2-opioid anesthesia.

作者信息

Lepage J Y, Malinovsky J M, Malinge M, Lechevalier T, Dupuch C, Cozian A, Pinaud M, Souron R

机构信息

Department of Anesthesiology, Hôtel-Dieu, Centre Hospitalier et Universitaire de Nantes, France.

出版信息

Anesth Analg. 1996 Oct;83(4):823-9. doi: 10.1097/00000539-199610000-00030.

DOI:10.1097/00000539-199610000-00030
PMID:8831329
Abstract

After administration of doses ranging from 0.025 to 0.25 mg/kg, the neuromuscular blocking effect of cisatracurium was assessed in 119 adult surgical patients receiving N2O-opioid-midazolam-thiopental anesthesia. The calculated 95% effective dose (ED95) for inhibition of adductor pollicis twitch evoked at 0.1 Hz was 0.053 mg/kg. With 0.10 mg/kg injected over 5-10 and 20-30 s, median onset times (range) were 5.8 (3.0-7.7) and 4.8 (1.2-10.2) min, respectively, and median times to 5% and 95% recovery (range) were 27 (19-46) and 48 (25-68) min, respectively. For doses of 0.10, 0.20, and 0.25 mg/kg, median 5%-95% and 25%-75% recovery indexes ranged from 48 to 90 min and 8 to 9 min, respectively. After administration of neostigmine (0.06 mg/kg) at 10%-15% or 16%-30% recovery, the median times to 95% recovery (range) were 6 (2-22) and 4 (2-5) min, respectively. There were no changes in heart rate, blood pressure, or plasma histamine concentrations during the first 5 min after administration of cisatracurium at doses up to 5 x ED95 injected over 5-10 s. No cutaneous flushing or bronchospasm was noted. In summary, cisatracurium is a potent neuromuscular blocking drug with an intermediate duration of action, characterized by excellent cardiovascular stability, with no apparent histamine release.

摘要

在对119例接受氧化亚氮-阿片类药物-咪达唑仑-硫喷妥钠麻醉的成年外科患者给予0.025至0.25mg/kg不等剂量的顺式阿曲库铵后,评估其神经肌肉阻滞作用。抑制拇内收肌在0.1Hz频率下诱发抽搐的计算95%有效剂量(ED95)为0.053mg/kg。分别以0.10mg/kg在5 - 10秒和20 - 30秒内注射,中位起效时间(范围)分别为5.8(3.0 - 7.7)分钟和4.8(1.2 - 10.2)分钟,至5%和95%恢复的中位时间(范围)分别为27(19 - 46)分钟和48(25 - 68)分钟。对于0.10、0.20和0.25mg/kg的剂量,中位5% - 95%和25% - 75%恢复指数分别为48至90分钟和8至9分钟。在恢复至10% - 15%或16% - 30%时给予新斯的明(0.06mg/kg)后,至95%恢复的中位时间(范围)分别为6(2 - 22)分钟和4(2 - 5)分钟。在以高达5倍ED95的剂量经5 - 10秒注射顺式阿曲库铵后的最初5分钟内,心率、血压或血浆组胺浓度无变化。未观察到皮肤潮红或支气管痉挛。总之,顺式阿曲库铵是一种强效神经肌肉阻滞药物,作用持续时间中等,具有出色的心血管稳定性,且无明显组胺释放。

相似文献

1
Pharmacodynamic dose-response and safety study of cisatracurium (51W89) in adult surgical patients during N2O-O2-opioid anesthesia.顺式阿曲库铵(51W89)在氧化亚氮-氧气-阿片类麻醉期间用于成年外科手术患者的药效学剂量反应及安全性研究。
Anesth Analg. 1996 Oct;83(4):823-9. doi: 10.1097/00000539-199610000-00030.
2
The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.51W89在接受氧化亚氮/阿片类药物/巴比妥类麻醉的患者中的心血管效应及组胺释放特性。
Anesthesiology. 1995 May;82(5):1131-8. doi: 10.1097/00000542-199505000-00007.
3
Effects of cisatracurium in children during halothane-nitrous oxide anesthesia.顺式阿曲库铵在氟烷-氧化亚氮麻醉期间对儿童的影响。
J Clin Anesth. 1998 May;10(3):195-9. doi: 10.1016/s0952-8180(98)00007-5.
4
The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.51W89在接受氧化亚氮/阿片类药物/巴比妥类麻醉患者中的临床神经肌肉药理学。
Anesthesiology. 1995 May;82(5):1139-45. doi: 10.1097/00000542-199505000-00008.
5
Cisatracurium during halothane and balanced anaesthesia in children.儿童氟烷麻醉和平衡麻醉期间的顺式阿曲库铵
Paediatr Anaesth. 1996;6(5):373-8. doi: 10.1046/j.1460-9592.1996.d01-8.x.
6
The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.门诊麻醉期间顺式阿曲库铵与维库溴铵的临床神经肌肉药理学
Anesth Analg. 1997 Dec;85(6):1278-83. doi: 10.1097/00000539-199712000-00018.
7
Tracheal intubating conditions and pharmacodynamics following cisatracurium in infants and children undergoing halothane and thiopental-fentanyl anesthesia.在接受氟烷和硫喷妥钠-芬太尼麻醉的婴幼儿中,顺式阿曲库铵后的气管插管条件及药效学。
Paediatr Anaesth. 2007 Feb;17(2):113-20. doi: 10.1111/j.1460-9592.2006.02042.x.
8
Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats.顺式阿曲库铵(51W89)、阿曲库铵及其五种异构体在猫体内的比较药理学
Anesthesiology. 1996 Jul;85(1):169-77. doi: 10.1097/00000542-199607000-00023.
9
Factors predicting atracurium reversal time.预测阿曲库铵恢复时间的因素。
Acta Anaesthesiol Scand. 1999 Sep;43(8):834-41. doi: 10.1034/j.1399-6576.1999.430809.x.
10
Comparison of neuromuscular effects, efficacy and safety of rocuronium and atracurium in ambulatory anaesthesia.罗库溴铵与阿曲库铵在门诊麻醉中神经肌肉效应、疗效及安全性的比较。
Can J Anaesth. 1998 Oct;45(10):954-9. doi: 10.1007/BF03012303.

引用本文的文献

1
Comparison of the Effects of Rocuronium Bromide and Cisatracurium Besylate on Intubating Conditions and Haemodynamic Response.罗库溴铵与顺式阿曲库铵对插管条件及血流动力学反应影响的比较
Cureus. 2024 Apr 8;16(4):e57878. doi: 10.7759/cureus.57878. eCollection 2024 Apr.
2
Atracurium Versus Cis-Atracurium for Laryngeal Relaxation and Hemodynamic Stability in Pediatric Patients: A Randomized, Double-Blind Study.阿曲库铵与顺式阿曲库铵用于小儿患者喉部松弛和血流动力学稳定性的比较:一项随机双盲研究
Cureus. 2023 Jun 24;15(6):e40882. doi: 10.7759/cureus.40882. eCollection 2023 Jun.
3
Pharmacokinetics and pharmacodynamics studies of a loading dose of cisatracurium in critically ill patients with respiratory failure.
负荷剂量顺式阿曲库铵在呼吸衰竭危重症患者中的药代动力学和药效学研究。
BMC Anesthesiol. 2022 Jan 22;22(1):32. doi: 10.1186/s12871-022-01571-2.
4
MRGPRX2 and Adverse Drug Reactions.MRGPRX2 与药物不良反应。
Front Immunol. 2021 Aug 6;12:676354. doi: 10.3389/fimmu.2021.676354. eCollection 2021.
5
The median effective dose (ED50) of cis-Atracurium for laryngeal mask airway insertion during general Anaesthesia for patients undergoing urinary surgery.全麻下经尿道手术患者行喉罩置入时顺式阿曲库铵的半数有效剂量(ED50)。
BMC Anesthesiol. 2020 Mar 19;20(1):68. doi: 10.1186/s12871-020-00982-3.
6
Effective doses of cisatracurium in the adult and the elderly.顺式阿曲库铵在成人和老年人中的有效剂量。
Korean J Anesthesiol. 2016 Oct;69(5):453-459. doi: 10.4097/kjae.2016.69.5.453. Epub 2016 Sep 8.
7
Altered pharmacodynamics and pharmacokinetics of cisatracurium in patients with severe mitral valve regurgitation during anaesthetic induction period.重度二尖瓣反流患者在麻醉诱导期顺式阿曲库铵的药效学和药代动力学改变。
Br J Clin Pharmacol. 2017 Feb;83(2):363-369. doi: 10.1111/bcp.13121. Epub 2016 Oct 16.
8
Autophagic Cell Death and Apoptosis Jointly Mediate Cisatracurium Besylate-Induced Cell Injury.自噬性细胞死亡和凋亡共同介导苯磺顺阿曲库铵诱导的细胞损伤。
Int J Mol Sci. 2016 Apr 6;17(4):515. doi: 10.3390/ijms17040515.
9
Pharmacodynamics of cisatracurium in the intensive care unit: an observational study.重症监护病房中顺式阿曲库铵的药效学:一项观察性研究。
Ann Intensive Care. 2014 Feb 11;4(1):3. doi: 10.1186/2110-5820-4-3.
10
Physiological modeling for indirect evaluation of drug tissular pharmacokinetics under non-steady-state conditions: an example of antimicrobial prophylaxis during liver surgery.非稳态条件下药物组织药代动力学间接评估的生理模型:肝手术中抗菌预防的实例
J Pharmacokinet Pharmacodyn. 2005 Feb;32(1):1-32. doi: 10.1007/s10928-005-2101-0.